世界における黒色腫検査製品のパイプライン動向2015...市場調査レポートについてご紹介

【英文タイトル】Melanoma - Pipeline Review, 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 8
2 Introduction 9
2.1 Melanoma Overview 9
3 Products under Development 10
3.1 Melanoma – Pipeline Products by Stage of Development 10
3.2 Melanoma – Pipeline Products by Territory 11
3.3 Melanoma – Pipeline Products by Regulatory Path 12
3.4 Melanoma – Pipeline Products by Estimated Approval Date 13
3.5 Melanoma – Ongoing Clinical Trials 14
4 Melanoma – Pipeline Products under Development by Companies 15
4.1 Melanoma Companies – Pipeline Products by Stage of Development 15
4.2 Melanoma – Pipeline Products by Stage of Development 17
5 Melanoma Companies and Product Overview 19
5.1 Abbott Diagnostics Company Overview 19
5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 19
5.2 Adaptive Biotechnologies Corporation Company Overview 23
5.2.1 Adaptive Biotechnologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 23
5.3 Advanced Cell Diagnostics, Inc. Company Overview 25
5.3.1 Advanced Cell Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
5.4 Agilent Technologies, Inc. Company Overview 26
5.4.1 Agilent Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
5.5 BioMarker Strategies, LLC Company Overview 28
5.5.1 BioMarker Strategies, LLC Pipeline Products & Ongoing Clinical Trials Overview 28
5.6 Biosceptre (Aust) Pty Ltd Company Overview 30
5.6.1 Biosceptre (Aust) Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 30
5.7 Boston University Company Overview 31
5.7.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 31
5.8 Ceres Nanosciences, Inc. Company Overview 32
5.8.1 Ceres Nanosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
5.9 Dana-Farber Cancer Institute, Inc. Company Overview 33
5.9.1 Dana-Farber Cancer Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
5.10 Digna Biotech, S.L. Company Overview 34
5.10.1 Digna Biotech, S.L. Pipeline Products & Ongoing Clinical Trials Overview 34
5.11 Exosomics Siena SpA Company Overview 35
5.11.1 Exosomics Siena SpA Pipeline Products & Ongoing Clinical Trials Overview 35
5.12 Genomic Health, Inc. Company Overview 36
5.12.1 Genomic Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.13 Hospital Universitario Cruces Company Overview 38
5.13.1 Hospital Universitario Cruces Pipeline Products & Ongoing Clinical Trials Overview 38
5.14 HTG Molecular Diagnostics, Inc. Company Overview 39
5.14.1 HTG Molecular Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 39
5.15 ImmunID Technologies Company Overview 41
5.15.1 ImmunID Technologies Pipeline Products & Ongoing Clinical Trials Overview 41
5.16 InterGenetics Incorporated Company Overview 45
5.16.1 InterGenetics Incorporated Pipeline Products & Ongoing Clinical Trials Overview 45
5.17 IV Diagnostics, Inc. Company Overview 46
5.17.1 IV Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
5.18 Louisville Bioscience, Inc. Company Overview 47
5.18.1 Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
5.19 MDNA Life Sciences, Inc. Company Overview 48
5.19.1 MDNA Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
5.20 Melanovus Oncology, Inc. Company Overview 49
5.20.1 Melanovus Oncology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
5.21 MolecularMD, Corp. Company Overview 50
5.21.1 MolecularMD, Corp. Pipeline Products & Ongoing Clinical Trials Overview 50
5.22 Myriad Genetics, Inc. Company Overview 51
5.22.1 Myriad Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 51
5.23 Orion Genomics LLC Company Overview 53
5.23.1 Orion Genomics LLC Pipeline Products & Ongoing Clinical Trials Overview 53
5.24 Oryzon Genomics S.A. Company Overview 54
5.24.1 Oryzon Genomics S.A. Pipeline Products & Ongoing Clinical Trials Overview 54
5.25 Pacific Edge Limited Company Overview 56
5.25.1 Pacific Edge Limited Pipeline Products & Ongoing Clinical Trials Overview 56
5.26 Qiagen N.V. Company Overview 58
5.26.1 Qiagen N.V. Pipeline Products & Ongoing Clinical Trials Overview 58
5.27 Roche Diagnostics International Ltd. Company Overview 60
5.27.1 Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview 60
5.28 Rosetta Genomics, Ltd. Company Overview 64
5.28.1 Rosetta Genomics, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 64
5.29 Sividon Diagnostics GmbH Company Overview 66
5.29.1 Sividon Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 66
5.30 SomaLogic, Inc. Company Overview 67
5.30.1 SomaLogic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
5.31 The Johns Hopkins University Company Overview 68
5.31.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 68
5.32 University of California, San Francisco Company Overview 70
5.32.1 University of California, San Francisco Pipeline Products & Ongoing Clinical Trials Overview 70
5.33 University of Colorado Company Overview 72
5.33.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 72
5.34 University of Louisville Company Overview 73
5.34.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 73
5.35 Zymera, Inc Company Overview 74
5.35.1 Zymera, Inc Pipeline Products & Ongoing Clinical Trials Overview 74
6 Melanoma- Recent Developments 75
7 Appendix 83
7.1 Methodology 83
7.2 About GlobalData 85
7.3 Contact Us 86
7.4 Disclaimer 86


【レポート販売概要】

■ タイトル:世界における黒色腫検査製品のパイプライン動向2015
■ 英文:Melanoma - Pipeline Review, 2015
■ 発行日:2015年10月1日
■ 調査会社:GlobalData
■ 商品コード:GDME0078EPD
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。